Signos announced today that it launched its FDA-cleared over-the-counter (OTC) glucose monitoring system for weight management. Palo Alto, California-based Signos integrated the Dexcom Stelo OTC continuous glucose monitor (CGM) with an AI-powered platform for deciphering unique metabolisms. It aims to help people see how food choices, timing, activity, stress and sleep affects their bodies in […]
Signos
Signos raises $20M for AI-powered CGM tech with backing from Google Ventures, Dexcom Ventures
Signos announced that it raised $20 million in a Series B round to support its AI-powered continuous glucose monitor (CGM) technology. San Francisco-based Signos develops a comprehensive metabolic health platform. It includes a proprietary AI engine with a CGM to provide real-time data and recommendations for weight management. Signos aims for its metabolic-led solution to […]
